SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1920212223242526Next Page
2026-07-28BCLI4SEC Filing Summary for BRAINSTORM CELL THERAPEUTICS INC.MEDIUM
Jacob A. Frenkel, a director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), acquired 100,000 shares of restricted stock units (RSUs) on July 24, 2026. These RSUs were issued under a Consulting Agreement and are subject to the 2014 Global Share Option Plan. The RSUs will vest in two tranches: 50% on October 24, 2026, and ...
Biotechnologyacquired_a
Previous Page1920212223242526Next Page